Table 3.
Effect of concomitant beta‐blocker use on BPa
| Number of paired readings (%) | ||
|---|---|---|
| BP | HR <60 bpm | HR ≥60 bpm |
| No relevant medication | ||
| ≥40 mmHg ↓ SBP | 14/4900 measurements (0.3) | 31/4900 measurements (0.6) |
| ≥30 mmHg ↓ DBP | 27/4900 measurements (0.6) | 36/4900 measurements (0.7) |
| Concomitant beta‐blockers | ||
| ≥40 mmHg ↓ SBP | 9/963 measurements (0.9) | 16/963 measurements (1.7) |
| ≥30 mmHg ↓ DBP | 17/963 measurements (1.8) | 19/963 measurements (2.0) |
bpm, beats per minute; DBP, diastolic blood pressure; HR, heart rate; SBP, systolic blood pressure.
a
The analyses included only patients with both baseline and postbaseline HR records. All available HR and BP records obtained at the same time at any planned and unplanned visit during concomitant beta‐blocker use were analyzed. Once the concomitant medication was stopped, the records were excluded from the analysis.